Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Tsukushi helps control inflammation and aids in wound healing.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Future acne treatments should aggressively target inflammation to prevent scarring.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

Alopecia Areata might be linked to Crohn's disease.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

UV-B light increases inflammation-related substances in acne-related skin cells.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

The substance from human hair root cells can help maintain hair growth and make skin cells more capable of growing hair.